Innovative Veterinary Solutions for Antimicrobial Resistance (InnoVet-AMR) will fund research to develop new animal vaccines and other innovations to fight antimicrobial resistance (AMR) in livestock and aquaculture production, particularly in low and middle-income countries (LMICs).
InnoVet-AMR responds to a need identified by the international scientific and development communities. It is supported with high-level policy processes including the:
- UN political declaration on AMR (2016);
- Global Health Security Agenda and Action Plan; as well as
- Global Action Plans of the World Health Assembly and the World Organization for Animal Health.
The initiative builds on DHSC’s expertise championing innovation by supporting research and technology to improve lives. It also draws on IDRC’s history as an experienced development research funder with a proven record in building knowledge-focused, cross-sector partnerships in areas including vaccine research and manufacturing, gender transformative research, public health, and sustainable agricultural development.
Through InnoVet-AMR, IDRC and DHSC aim to achieve two main objectives:
- Support research that will identify innovative veterinary solutions, including vaccines and alternative solutions, to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs;
- Build effective partnerships to better coordinate discovery, development, and sustainable delivery of innovative veterinary solutions to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs.
The InnoVet-AMR partnership was launched at a special event held in collaboration with Wilton Park, an international forum for strategic discussion.
“Antimicrobial resistance ultimately endangers health, food security, economic development, and international trade, and it poses a threat to human health,” said IDRC President Jean Lebel. “Beyond its deep impacts on livestock keepers in low and middle-income countries, AMR threatens to undermine the fight against infectious disease. The stakes are high and the window of opportunity is now. Through InnoVet-AMR, we look forward to working with our UK partners to lead a research-driven response to this critical global issue.”
A key element of the partnership will be an associated funding opportunity, to be launched over the coming months. More information will be released closer to the funding call announcement.
Learn more about InnoVet-AMR.